These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29956793)

  • 1. Thymoquinone inhibits metastatic phenotype and epithelial‑mesenchymal transition in renal cell carcinoma by regulating the LKB1/AMPK signaling pathway.
    Kou B; Kou Q; Ma B; Zhang J; Sun B; Yang Y; Li J; Zhou J; Liu W
    Oncol Rep; 2018 Sep; 40(3):1443-1450. PubMed ID: 29956793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymoquinone inhibits the metastasis of renal cell cancer cells by inducing autophagy via AMPK/mTOR signaling pathway.
    Zhang Y; Fan Y; Huang S; Wang G; Han R; Lei F; Luo A; Jing X; Zhao L; Gu S; Zhao X
    Cancer Sci; 2018 Dec; 109(12):3865-3873. PubMed ID: 30259603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oridonin inhibited epithelial-mesenchymal transition of laryngeal carcinoma by positively regulating LKB1/AMPK signaling.
    Kou B; Shi Y; Zhou Z; Yun Y; Wu Q; Zhou J; Liu W
    Int J Med Sci; 2024; 21(4):623-632. PubMed ID: 38464825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymoquinone alleviates thioacetamide-induced hepatic fibrosis and inflammation by activating LKB1-AMPK signaling pathway in mice.
    Bai T; Yang Y; Wu YL; Jiang S; Lee JJ; Lian LH; Nan JX
    Int Immunopharmacol; 2014 Apr; 19(2):351-7. PubMed ID: 24560906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of SIRT1-AMPK by thymoquinone in hepatic stellate cells ameliorates liver injury.
    Yang Y; Bai T; Yao YL; Zhang DQ; Wu YL; Lian LH; Nan JX
    Toxicol Lett; 2016 Nov; 262():80-91. PubMed ID: 27688165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway.
    Hong X; Yu JJ
    Int J Oncol; 2019 May; 54(5):1676-1690. PubMed ID: 30816490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UBE2T promotes proliferation and regulates PI3K/Akt signaling in renal cell carcinoma.
    Hao P; Kang B; Li Y; Hao W; Ma F
    Mol Med Rep; 2019 Aug; 20(2):1212-1220. PubMed ID: 31173226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymoquinone Inhibits Angiotensin II-Induced Proliferation and Migration of Vascular Smooth Muscle Cells Through the AMPK/PPARγ/PGC-1α Pathway.
    Pei X; Li X; Chen H; Han Y; Fan Y
    DNA Cell Biol; 2016 Aug; 35(8):426-33. PubMed ID: 27064837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parthenolide inhibits the tumor characteristics of renal cell carcinoma.
    Liu D; Han Y; Liu L; Ren X; Zhang H; Fan S; Qin T; Li L
    Int J Oncol; 2021 Jan; 58(1):100-110. PubMed ID: 33367934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymoquinone Attenuates Acetaminophen Overdose-Induced Acute Liver Injury and Inflammation Via Regulation of JNK and AMPK Signaling Pathway.
    Cui BW; Bai T; Yang Y; Zhang Y; Jiang M; Yang HX; Wu M; Liu J; Qiao CY; Zhan ZY; Wu YL; Kang DZ; Lian LH; Nan JX
    Am J Chin Med; 2019; 47(3):577-594. PubMed ID: 30974967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymoquinone inhibits metastasis of renal cell carcinoma cell 786-O-SI3 associating with downregulation of MMP-2 and u-PA and suppression of PI3K/Src signaling.
    Liou YF; Hsieh YS; Hung TW; Chen PN; Chang YZ; Kao SH; Lin SW; Chang HR
    Int J Med Sci; 2019; 16(5):686-695. PubMed ID: 31217736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymoquinone induces apoptosis of human renal carcinoma Caki-1 cells by inhibiting JAK2/STAT3 through pro-oxidant effect.
    Chae IG; Song NY; Kim DH; Lee MY; Park JM; Chun KS
    Food Chem Toxicol; 2020 May; 139():111253. PubMed ID: 32165235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salinomycin suppresses cancer cell stemness and attenuates TGF-β-induced epithelial-mesenchymal transition of renal cell carcinoma cells.
    Liu L; Wang Q; Mao J; Qin T; Sun Y; Yang J; Han Y; Li L; Li Q
    Chem Biol Interact; 2018 Dec; 296():145-153. PubMed ID: 30273566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of SIRT1/AMPK signaling in the proliferation, migration and invasion of renal cell carcinoma cells.
    Wang X; Lu Y; Tuo Z; Zhou H; Zhang Y; Cao Z; Peng L; Yu D; Bi L
    Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33907836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RHBDD1 promotes proliferation, migration, invasion and EMT in renal cell carcinoma via the EGFR/AKT signaling pathway.
    Li M; Cai L; Wang X; Yu Y; Jian W; Bao G; Gao Z; Guo J; Zhang J; Li C; Zhang C
    Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34581421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-Ionone represses renal cell carcinoma progression through activating LKB1/AMPK-triggered autophagy.
    Hou T; Wang Y; Dan W; Wei Y; Liu B; Que T; Lei Y; Yu B; Zeng J; Fan Y; Li L
    J Biochem Mol Toxicol; 2023 Jun; 37(6):e23331. PubMed ID: 36843289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic AMP responsive element-binding protein induces metastatic renal cell carcinoma by mediating the expression of matrix metallopeptidase-2/9 and proteins associated with epithelial-mesenchymal transition.
    Wang X; Cui H; Lou Z; Huang S; Ren Y; Wang P; Weng G
    Mol Med Rep; 2017 Jun; 15(6):4191-4198. PubMed ID: 28487942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMGA2 facilitates epithelial-mesenchymal transition in renal cell carcinoma by regulating the TGF-β/Smad2 signaling pathway.
    Kou B; Liu W; Tang X; Kou Q
    Oncol Rep; 2018 Jan; 39(1):101-108. PubMed ID: 29138866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silibinin inhibits epithelial‑mesenchymal transition of renal cell carcinoma through autophagy‑dependent Wnt/β‑catenin signaling.
    Fan Y; Hou T; Dan W; Liu T; Luan J; Liu B; Li L; Zeng J
    Int J Mol Med; 2020 May; 45(5):1341-1350. PubMed ID: 32323735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproic acid inhibits epithelial‑mesenchymal transition in renal cell carcinoma by decreasing SMAD4 expression.
    Mao S; Lu G; Lan X; Yuan C; Jiang W; Chen Y; Jin X; Xia Q
    Mol Med Rep; 2017 Nov; 16(5):6190-6199. PubMed ID: 28901475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.